Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market to reach USD XX billion by the end of 2029

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Size study & Forecast, by Service Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing) and Regional Analysis, 2022-2029

Product Code: HLSHS-44574340
Publish Date: 9-05-2023
Page: 200

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Contract manufacturing is outsourcing where a manufacturer enters a formal agreement with another manufacturing company for its parts, goods, or components. A contract manufacturing organization (CMO) is an organization that caters to the pharmaceutical sector and offers clients entire services from manufacturing to drug research. CMOs provide services ranging from drug development, manufacturing, packaging, labeling, and distribution to their clients. Pharmaceutical clients can extend their technical resources by outsourcing to a CMO without incurring more overhead. By concentrating on core capabilities and high-value projects while decreasing or not increasing infrastructure or technical people, the client may manage its internal resources and costs. The business controls internal costs and resources by concentrating on core skills and high-value initiatives while decreasing or not increasing infrastructure or technical staff. The market growth is primarily driven by the factors such as surging demand for generic drugs, rising outsourcing volume by pharmaceutical companies, and increasing prevalence of various diseases.

In addition, the growing investment in research and development activities across the pharmaceutical industry is playing a significant role in market growth across the globe. As per Statista, in 2020, the total overall R&D spending in the pharmaceutical sector accounted for USD 198 billion and it is projected to reach around USD 248 billion by the year 2025. Consequentially, these aforementioned factors are propelling the market’s development globally. Moreover, the rising number of government initiatives, as well as expansion in emerging countries are presenting various lucrative opportunities over the forecasting years. However, the stringent regulatory requirements and increasing lead time and logistics costs are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pharmaceutical Contract Manufacturing Organization (CMO) Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising number of clinical trials in the region, along with the presence of advanced manufacturing capabilities. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as favorable government policies, growing investment in R&D, as well as rising outsourcing volume by pharmaceutical companies in the market space.

Major market players included in this report are:
Catalent Inc.
Recipharm AB
Jubilant Biosys Ltd. (Jubilant Pharmova Ltd)
Patheon Inc. (Thermo Fisher Scientific Inc.)
Boehringer Ingelheim Group
Pfizer CentreSource (Pfizer Inc.)
Aenova Group
Famar SA
Baxter Biopharma Solutions (Baxter International Inc.)
Lonza Group AG

Recent Developments in the Market:
Ø In March 2022, Sterling Drug Solutions UK, a global CDMO, and Novartis announced an agreement for Sterling to purchase Novartis’ Ringaskiddy campus (formerly known as Novartis Ringaskiddy Limited) in Ireland. The company acquired the 111-acre site that involves three active pharmaceutical ingredient (API) manufacturing buildings, along with facilities to support the development and scale-up in line with Sterling’s core business focus.
Ø In March 2022, Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The upgrades increase the development laboratories’ capacity and capabilities while enabling kilogram-scale production of highly potent APIs (HPAPIs), which have grown to play a significant role in the company’s small-molecule development pipeline.

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Service Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Service Type:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development and Manufacturing

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Service Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Dynamics
3.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising outsourcing volume by pharmaceutical companies
3.1.1.2. Growing investment in research and development activities across the pharmaceutical industry
3.1.2. Market Challenges
3.1.2.1. Stringent regulatory requirements
3.1.2.2. Increasing lead time and logistics costs
3.1.3. Market Opportunities
3.1.3.1. Rising number of government initiatives
3.1.3.2. Expansion in emerging countries
Chapter 4. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Service Type
6.1. Market Snapshot
6.2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by Service Type, Performance – Potential Analysis
6.3. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Estimates & Forecasts by Service Type 2019-2029 (USD Billion)
6.4. Pharmaceutical Contract Manufacturing Organization (CMO) Market, Sub Segment Analysis
6.4.1. Active Pharmaceutical Ingredient (API) Manufacturing
6.4.2. Finished Dosage Formulation (FDF) Development and Manufacturing
Chapter 7. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, Regional Analysis
7.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market, Regional Market Snapshot
7.2. North America Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.2.1. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.2.1.1. Service Type breakdown estimates & forecasts, 2019-2029
7.2.2. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3. Europe Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
7.3.1. U.K. Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.2. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.3. France Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.4. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.5. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.6. Rest of Europe Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4. Asia-Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
7.4.1. China Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.2. India Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.3. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.4. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.5. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.6. Rest of Asia Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.5. Latin America Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
7.5.1. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.5.2. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.5.3. Rest of Latin America Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.6. Rest of The World Pharmaceutical Contract Manufacturing Organization (CMO) Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Catalent Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Recipharm AB
8.2.3. Jubilant Biosys Ltd. (Jubilant Pharmova Ltd)
8.2.4. Patheon Inc. (Thermo Fisher Scientific Inc.)
8.2.5. Boehringer Ingelheim Group
8.2.6. Pfizer CentreSource (Pfizer Inc.)
8.2.7. Aenova Group
8.2.8. Famar SA
8.2.9. Baxter Biopharma Solutions (Baxter International Inc.)
8.2.10. Lonza Group AG
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now